Merit Medical’s Fred Lampropoulos Honored by Nasdaq
December 29, 2025
Nasdaq congratulated Fred Lampropoulos, founder and executive chairman of Merit Medical, on receiving the 2025 BioUtah Executive of the Year Award—a distinction reserved for executives whose vision and influence have not only propelled their organizations to sustained success but have also shaped the future of global healthcare.
Congratulations to Fred on receiving the well-deserved BioUtah award, as well as this recognition from Nasdaq!
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
